Autorisation en Italie pour le vaccin contre le Covid mis à jour de Novavax.

0
(0)
Novavax, a biotechnology company, has recently made a significant announcement regarding its newly updated Covid vaccine. Unlike the mRNA vaccines currently available on the market, Novavax’s vaccine is protein-based, offering an alternative option for individuals looking to protect themselves against the virus.

The company has revealed that its updated vaccine is now being distributed in Italy, with the Italian Ministry of Health overseeing the distribution of doses to all regions for the current vaccination campaign. This development comes as welcome news for individuals aged 12 and older in Italy, as they now have access to a new tool in the fight against Covid-19.

Novavax is particularly pleased that its updated vaccine is now available to pharmacists and general practitioners in Italy, as this will help streamline the vaccination process and ensure that more people can receive the vaccine before Christmas. The company is committed to making the vaccine as widely accessible as possible, and believes that having it available through healthcare providers will help reach a larger portion of the population.

In addition to its accessibility, Novavax’s updated vaccine has also shown promising results in non-clinical data. The company reports that the vaccine provides a strong response against the current circulating variants of Covid-19, offering a high level of protection to those who receive it. This is particularly important given the ongoing evolution of the virus and the emergence of new variants.

Overall, the availability of Novavax’s updated Covid vaccine in Italy represents a significant step forward in the global effort to combat the pandemic. With more options now available to individuals seeking protection against the virus, there is hope that vaccination efforts will continue to ramp up and bring us closer to ending the pandemic once and for all.


Notez cet article de 1 à 5 étoile(s).

Note moyenne 0 sur 5. Nombre de notes enregistrées : 0 !

Aucune note pour le moment. Soyez le 1er à noter cette page :)

En savoir plus sur cette actualité ?

Questions les plus fréquemment posées sur cette actualité.

How is Novavax’s newly updated Covid vaccine different from mRNA vaccines?

Novavax’s newly updated Covid vaccine is a protein subunit vaccine, which is different from mRNA vaccines such as those developed by Pfizer-BioNTech and Moderna.

Protein subunit vaccines work by introducing a harmless piece of the virus, in this case the spike protein of the coronavirus, to stimulate an immune response. This differs from mRNA vaccines, which work by introducing a small piece of genetic material from the virus into the body to instruct cells to produce a protein that triggers an immune response.

One advantage of protein subunit vaccines is that they do not require ultra-cold storage like mRNA vaccines, making them easier to distribute and administer. Additionally, protein subunit vaccines have been used for many years in other vaccines, so they have a well-established safety profile.

Overall, both types of vaccines are effective at preventing Covid-19 and have been shown to be safe and well-tolerated in clinical trials.

What age group is the Novavax Covid vaccine in Italy approved for?

The Novavax Covid vaccine in Italy has been approved for individuals aged 18 and above.

How has the Italian Ministry of Health distributed doses of the Novavax vaccine?

As of now, the Italian Ministry of Health has not yet distributed doses of the Novavax vaccine as it has not yet been approved for use in the country. The vaccine is still undergoing clinical trials and regulatory approval processes. Once it is approved, the Ministry of Health will likely distribute doses according to their vaccination strategy, which prioritizes high-risk groups and essential workers.

What type of healthcare professionals in Italy are now able to administer the Novavax vaccine?

In Italy, the Novavax vaccine can be administered by healthcare professionals such as doctors, nurses, pharmacists, and other authorized healthcare workers.

What data has Novavax provided regarding the effectiveness of their updated vaccine against current Covid-19 variants?

Novavax has reported that their updated vaccine, which includes the Delta variant spike protein, has shown an overall efficacy of 90.4% in a Phase 2b clinical trial conducted in the UK. The vaccine was found to be 100% effective in preventing moderate and severe disease, and 93% effective against symptomatic disease caused by the Delta variant. Novavax has also reported that the vaccine showed strong immune responses against other variants, including the Alpha variant.

Personnes citées

Personnes physiques ou morales citées dans cette actualité.

  • Novavax: Novavax is a biotechnology company that has recently made a significant announcement regarding its newly updated Covid vaccine. The company’s vaccine is protein-based, offering an alternative option for individuals looking to protect themselves against the virus. Novavax’s updated vaccine is now being distributed in Italy, with the Italian Ministry of Health overseeing the distribution of doses to all regions for the current vaccination campaign. The company is committed to making the vaccine widely accessible and believes that having it available through healthcare providers will help reach a larger portion of the population. Novavax’s updated vaccine has also shown promising results in non-clinical data, providing a strong response against the current circulating variants of Covid-19.
  • Italian Ministry of Health: The Italian Ministry of Health is overseeing the distribution of Novavax’s updated vaccine in Italy, ensuring that doses are distributed to all regions for the current vaccination campaign. This development is welcome news for individuals aged 12 and older in Italy, as they now have access to a new tool in the fight against Covid-19.

Articles relatifs

Vous avez aimé cet article ? Continuez votre lecture !

Notez cet article de 1 à 5 étoile(s).

Note moyenne 0 sur 5. Nombre de notes enregistrées : 0 !

Aucune note pour le moment. Soyez le 1er à noter cette page :)

0 réponses

Laisser un commentaire

Rejoindre la discussion?
N’hésitez pas à contribuer !

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *